Your browser doesn't support javascript.
loading
A high-risk retinoblastoma subtype with stemness features, dedifferentiated cone states and neuronal/ganglion cell gene expression.
Liu, Jing; Ottaviani, Daniela; Sefta, Meriem; Desbrousses, Céline; Chapeaublanc, Elodie; Aschero, Rosario; Sirab, Nanor; Lubieniecki, Fabiana; Lamas, Gabriela; Tonon, Laurie; Dehainault, Catherine; Hua, Clément; Fréneaux, Paul; Reichman, Sacha; Karboul, Narjesse; Biton, Anne; Mirabal-Ortega, Liliana; Larcher, Magalie; Brulard, Céline; Arrufat, Sandrine; Nicolas, André; Elarouci, Nabila; Popova, Tatiana; Némati, Fariba; Decaudin, Didier; Gentien, David; Baulande, Sylvain; Mariani, Odette; Dufour, Florent; Guibert, Sylvain; Vallot, Céline; Rouic, Livia Lumbroso-Le; Matet, Alexandre; Desjardins, Laurence; Pascual-Pasto, Guillem; Suñol, Mariona; Catala-Mora, Jaume; Llano, Genoveva Correa; Couturier, Jérôme; Barillot, Emmanuel; Schaiquevich, Paula; Gauthier-Villars, Marion; Stoppa-Lyonnet, Dominique; Golmard, Lisa; Houdayer, Claude; Brisse, Hervé; Bernard-Pierrot, Isabelle; Letouzé, Eric; Viari, Alain; Saule, Simon.
Afiliación
  • Liu J; Institut Curie, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, PSL Research University, 75005, Paris, France.
  • Ottaviani D; Sorbonne Universités, UPMC Université Paris 06, CNRS, UMR144, 75005, Paris, France.
  • Sefta M; Programme Cartes d'Identité des Tumeurs, Ligue Nationale Contre le Cancer, 75013, Paris, France.
  • Desbrousses C; Institut Curie, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, PSL Research University, 75005, Paris, France.
  • Chapeaublanc E; Sorbonne Universités, UPMC Université Paris 06, CNRS, UMR144, 75005, Paris, France.
  • Aschero R; Precision Medicine, Hospital J.P. Garrahan, Buenos Aires, Argentina.
  • Sirab N; Institut Curie, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, PSL Research University, 75005, Paris, France.
  • Lubieniecki F; Sorbonne Universités, UPMC Université Paris 06, CNRS, UMR144, 75005, Paris, France.
  • Lamas G; Institut Curie, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, PSL Research University, 75005, Paris, France.
  • Tonon L; Sorbonne Universités, UPMC Université Paris 06, CNRS, UMR144, 75005, Paris, France.
  • Dehainault C; Institut Curie, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, PSL Research University, 75005, Paris, France.
  • Hua C; Sorbonne Universités, UPMC Université Paris 06, CNRS, UMR144, 75005, Paris, France.
  • Fréneaux P; Pathology Service, Hospital J.P. Garrahan, Buenos Aires, Argentina.
  • Reichman S; Institut Curie, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, PSL Research University, 75005, Paris, France.
  • Karboul N; Sorbonne Universités, UPMC Université Paris 06, CNRS, UMR144, 75005, Paris, France.
  • Biton A; Pathology Service, Hospital J.P. Garrahan, Buenos Aires, Argentina.
  • Mirabal-Ortega L; Pathology Service, Hospital J.P. Garrahan, Buenos Aires, Argentina.
  • Larcher M; Synergie Lyon Cancer, Plateforme de Bioinformatique "Gilles Thomas", Centre Léon Bérard, 69008, Lyon, France.
  • Brulard C; Département de Biologie des Tumeurs, Institut Curie, 75005, Paris, France.
  • Arrufat S; Service de Génétique, Institut Curie, 75005, Paris, France.
  • Nicolas A; Institut Curie, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, PSL Research University, 75005, Paris, France.
  • Elarouci N; Sorbonne Universités, UPMC Université Paris 06, CNRS, UMR144, 75005, Paris, France.
  • Popova T; Département de Biologie des Tumeurs, Institut Curie, 75005, Paris, France.
  • Némati F; Institut de la Vision, Sorbonne Université, INSERM, CNRS, 75012, Paris, France.
  • Decaudin D; Institut Curie, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, PSL Research University, 75005, Paris, France.
  • Gentien D; Sorbonne Universités, UPMC Université Paris 06, CNRS, UMR144, 75005, Paris, France.
  • Baulande S; Institut Curie, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, PSL Research University, 75005, Paris, France.
  • Mariani O; Sorbonne Universités, UPMC Université Paris 06, CNRS, UMR144, 75005, Paris, France.
  • Dufour F; Institut Curie, PSL Research University, INSERM, U900, 75005, Paris, France.
  • Guibert S; Ecole des Mines ParisTech, 77305, Fontainebleau, France.
  • Vallot C; Institut Pasteur - Hub Bioinformatique et Biostatistique - C3BI, USR 3756 IP CNRS, 75015, Paris, France.
  • Rouic LL; Institut Curie, CNRS, UMR3347, PSL Research University, 91405, Orsay, France.
  • Matet A; Institut Curie, PSL Research University, INSERM, U1021, 91405, Orsay, France.
  • Desjardins L; Université Paris-Saclay, 91405, Orsay, France.
  • Pascual-Pasto G; Institut Curie, CNRS, UMR3347, PSL Research University, 91405, Orsay, France.
  • Suñol M; Institut Curie, PSL Research University, INSERM, U1021, 91405, Orsay, France.
  • Catala-Mora J; Université Paris-Saclay, 91405, Orsay, France.
  • Llano GC; Institut Curie, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, PSL Research University, 75005, Paris, France.
  • Couturier J; Sorbonne Universités, UPMC Université Paris 06, CNRS, UMR144, 75005, Paris, France.
  • Barillot E; INSERM U930, CHU Bretonneau, 37000, Tours, France.
  • Schaiquevich P; Département de Biologie des Tumeurs, Institut Curie, 75005, Paris, France.
  • Gauthier-Villars M; Département de Biologie des Tumeurs, Institut Curie, 75005, Paris, France.
  • Stoppa-Lyonnet D; Programme Cartes d'Identité des Tumeurs, Ligue Nationale Contre le Cancer, 75013, Paris, France.
  • Golmard L; Institut Curie, PSL Research University, INSERM U830, 75005, Paris, France.
  • Houdayer C; Département de Recherche Translationnelle, Institut Curie, 75005, Paris, France.
  • Brisse H; Département de Recherche Translationnelle, Institut Curie, 75005, Paris, France.
  • Bernard-Pierrot I; Département de Recherche Translationnelle, Institut Curie, 75005, Paris, France.
  • Letouzé E; Institut Curie, PSL Research University, NGS Platform, 75005, Paris, France.
  • Viari A; Département de Biologie des Tumeurs, Institut Curie, 75005, Paris, France.
  • Saule S; Institut Curie, CNRS, UMR144, Equipe Labellisée Ligue contre le Cancer, PSL Research University, 75005, Paris, France.
Nat Commun ; 12(1): 5578, 2021 09 22.
Article en En | MEDLINE | ID: mdl-34552068
ABSTRACT
Retinoblastoma is the most frequent intraocular malignancy in children, originating from a maturing cone precursor in the developing retina. Little is known on the molecular basis underlying the biological and clinical behavior of this cancer. Here, using multi-omics data, we demonstrate the existence of two retinoblastoma subtypes. Subtype 1, of earlier onset, includes most of the heritable forms. It harbors few genetic alterations other than the initiating RB1 inactivation and corresponds to differentiated tumors expressing mature cone markers. By contrast, subtype 2 tumors harbor frequent recurrent genetic alterations including MYCN-amplification. They express markers of less differentiated cone together with neuronal/ganglion cell markers with marked inter- and intra-tumor heterogeneity. The cone dedifferentiation in subtype 2 is associated with stemness features including low immune and interferon response, E2F and MYC/MYCN activation and a higher propensity for metastasis. The recognition of these two subtypes, one maintaining a cone-differentiated state, and the other, more aggressive, associated with cone dedifferentiation and expression of neuronal markers, opens up important biological and clinical perspectives for retinoblastomas.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Ganglionares de la Retina / Retinoblastoma / Células Fotorreceptoras Retinianas Conos / Neoplasias de la Retina Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2021 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Células Ganglionares de la Retina / Retinoblastoma / Células Fotorreceptoras Retinianas Conos / Neoplasias de la Retina Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Nat Commun Asunto de la revista: BIOLOGIA / CIENCIA Año: 2021 Tipo del documento: Article País de afiliación: Francia